GLOBE LIFE INC. (GL) Stock News

Rosen Law Firm is soliciting investors who purchased securities of Ardelyx, Inc., Anavex Life Sciences Corp., and AST SpaceMobile, Inc. during specified periods to join class action lawsuits. The firm alleges these companies made materially false statements regarding commercial performance and growth prospects. Investors have until November 16, 2026 to serve as lead plaintiffs.

A securities class action lawsuit has been filed against DICK'S Sporting Goods, Inc. for allegedly making materially false and misleading statements regarding its Foot Locker acquisition cleanup efforts and exposure to industry-wide inventory and promotional pressures. Investors who purchased DKS common stock between September 8, 2025 and August 24, 2026 may be eligible for compensation. The lead plaintiff deadline is November 3, 2026.

GLP-1 weight-loss drugs like Wegovy and Zepbound are rapidly gaining adoption, with 11% of U.S. adults now using them. This is benefiting drug manufacturers Eli Lilly and Novo Nordisk, whose sales are surging. However, snack and beverage companies face headwinds as GLP-1 users reduce grocery spending by 5-8%, particularly on processed snacks. While some companies like Coca-Cola and Monster Beverage are weathering the impact due to their low-calorie portfolios, others like PepsiCo and Hershey are experiencing declining sales.

Rosen Law Firm is urging investors who purchased Doximity common stock between August 8, 2024 and May 13, 2026 to join a securities class action lawsuit before the November 16, 2026 lead plaintiff deadline. The lawsuit alleges that Doximity overstated the revenue impact of its Newsfeed feature, lost market share to competitors, and relied on less effective engagement tactics, causing investor damages when the truth emerged.

Rosen Law Firm has filed a class action lawsuit against Alphabet Inc. on behalf of investors who purchased securities between May 19, 2026 and July 16, 2026. The lawsuit alleges that Alphabet made materially false and misleading statements regarding the Gemini 3.5 Pro, claiming it delivered disappointing training results and would face significant launch delays. Investors who purchased during this period may be eligible for compensation. The deadline to serve as lead plaintiff is December 1, 2026.

GLOF is a smart beta ETF managed by BlackRock that tracks the STOXX Global Equity Factor Index with an expense ratio of 0.20%. The fund has $201.09 million in assets, holds approximately 723 stocks with top holdings including Nvidia, Apple, and Microsoft, and has delivered 16.38% year-to-date returns and 19.06% one-year returns as of October 2026.

Sol-Gel Technologies Ltd. (SLGL) received an upgrade to Zacks Rank #2 (Buy) based on upward trends in earnings estimates. The company's Zacks Consensus Estimate has increased 41.9% over the past three months, positioning it in the top 20% of Zacks-covered stocks for estimate revisions. The upgrade reflects improving business fundamentals that could drive near-term stock price appreciation.

The Oil and Gas - Refining & Marketing MLP industry is well-positioned with a Zacks Industry Rank of #40 (top 16%), supported by diversified business models, stronger balance sheets, and improving earnings expectations. The industry has outperformed the S&P 500 (46.2% vs 16.2% over the past year) and trades at a reasonable 12.25X EV/EBITDA. Three stocks highlighted are Western Midstream Partners (Rank #1), Global Partners (Rank #2), and NGL Energy Partners (Rank #3), each benefiting from fee-based contracts, integrated operations, and long-term commitments.

PepsiCo running out of time to meet Elliott-inspired targets as GLP-1 threat intensifies  Reuters

A securities class action lawsuit has been filed against DICK'S Sporting Goods, Inc. (DKS) for allegedly making materially false and misleading statements regarding its business operations. The lawsuit claims the company failed to disclose incomplete cleanup efforts from the Foot Locker acquisition, exposure to excess inventory, and promotional pressures that prevented achievement of promised sales growth and profits. Investors who purchased DKS stock between September 8, 2025 and August 24, 2026 may be eligible for compensation. The lead plaintiff deadline is November 3, 2026.

Halper Sadeh LLC, an investor rights law firm, is investigating three companies for potential securities law violations and breaches of fiduciary duties related to their proposed acquisitions. The firm is examining whether MISTRAS Group's $20.35/share sale to H.I.G. Capital, Lifecore Biomedical's $6.28/share sale to Webster Equity Partners, and Marygold Companies' $2.00/share sale to Madison Dearborn Partners represent fair deals for shareholders. The firm may seek increased consideration, additional disclosures, and other relief on behalf of shareholders.

Rosen Law Firm has filed a class action lawsuit against Qfin Holdings, Inc. on behalf of investors who purchased securities between March 18, 2026 and August 25, 2026. The lawsuit alleges that defendants made false and misleading statements regarding the resiliency of Qfin's business and downplayed the negative impact of regulatory headwinds on financial results. Investors who wish to serve as lead plaintiff must file by November 30, 2026.

Chaince Securities, LLC has been engaged as the exclusive sales agent for Magic Empire Global Limited's (NASDAQ: MEGL) $100 million at-the-market equity offering program. The offering allows MEGL to sell Class A ordinary shares at prevailing market prices, with proceeds intended for working capital and general corporate purposes. This engagement reflects Chaince's expansion of its equity capital markets platform serving Nasdaq-listed issuers.

Arch Capital Group (ACGL) declined 2.9% to $92.36, underperforming the S&P 500's 0.25% loss. The property and casualty insurer is expected to report earnings on October 27, 2026, with projected EPS of $1.88 (down 32.13% YoY) and revenue of $4.46 billion (down 5.4% YoY). The stock carries a Zacks Rank #3 (Hold) with a Forward P/E of 10.07, trading at a discount to its industry average.

Alphabet is leveraging AI adoption across Search, Google Cloud, YouTube, and Gemini to strengthen its competitive position against Meta and Reddit in digital advertising. Gemini AI Mode surpassed 1 billion monthly users while Google Cloud revenues surged 82% year-over-year. However, GOOGL stock trades at a premium valuation and underperformed the broader tech sector year-to-date, while competitors Reddit and Meta are also making significant AI-driven gains in ad monetization.

Novo Nordisk has entered into an exclusive license agreement with Hengrui Pharma for HRS-1596, a phase 1-ready once-weekly oral GLP-1/GIP dual receptor agonist. The deal is valued at up to $2.6 billion, including a $300 million upfront payment, with Novo obtaining global rights excluding mainland China, Hong Kong, Macao, and Taiwan. The drug targets obesity, type 2 diabetes, and other metabolic diseases.

Rosen Law Firm has issued multiple securities class action deadline alerts for investors. GoDaddy Inc. faces allegations of making false statements about customer growth strategy and average order size, with an October 20, 2026 lead plaintiff deadline. The firm is also handling class actions for FuelCell Energy Inc. and The Simply Good Foods Company with similar investor protection deadlines.

Rosen Law Firm is soliciting investors for multiple securities class action lawsuits. The primary case involves Unicycive Therapeutics, which allegedly made false statements about its manufacturing vendor's FDA compliance and the regulatory approval timeline for its drug oxylanthanum carbonate. The firm is also handling class actions for FuelCell Energy and GoDaddy, with lead plaintiff deadlines approaching in November 2026.

Rosen Law Firm announces a securities class action lawsuit against Flotek Industries, Inc. (FTK) for allegedly making materially false and misleading statements regarding a Puerto Rico Electric Power Authority (PREPA) power generation project contract. The lawsuit claims defendants failed to disclose credible doubts about the consortium parties' experience and financial capacity, creating risk that contract revenue would not be realized. The lead plaintiff deadline is October 26, 2026.

Viking Therapeutics' GLP-1 drug VK2735 showed promising clinical trial results with 16-19% weight loss and strong maintenance rates, causing the stock to surge. While riskier than Eli Lilly due to its smaller $4.1B market cap and lack of approved drugs, Viking could offer significant upside potential through drug approval or acquisition by a larger healthcare company.

Rosen Law Firm has filed securities class action lawsuits against DNOW Inc., Doximity Inc., and XTI Aerospace Inc., alleging false and misleading statements. The firm is seeking lead plaintiffs with an October 2, 2026 deadline for DNOW. Investors who held shares during specified periods may be eligible for compensation.

Rosen Law Firm reminds investors who purchased Innventure, Inc. (NASDAQ: INV) securities between November 17, 2025 and August 13, 2026 of the October 27, 2026 lead plaintiff deadline in an ongoing securities class action. The lawsuit alleges that Innventure made materially false statements regarding Accelsius Holdings LLC's transformative deal with DarkNX, which allegedly lacked evidence of execution, resulting in overstated revenue and cash flow targets for 2026.

Viking Therapeutics released positive maintenance dosing data for its GLP-1 drug candidate VK2735, causing the stock to surge 35%. The company is positioning itself as a potential competitor in the $100 billion weight loss drug market dominated by Eli Lilly and Novo Nordisk. Viking's dual GLP-1/GIP agonist could be the first oral formulation of its kind, with both injectable and oral versions available, offering advantages over current competitors.

Rosen Law Firm has filed securities class action lawsuits against AppLovin Corporation, UWM Holdings Corporation, and DNOW Inc. on behalf of investors who purchased securities during specified periods. AppLovin faces allegations of making false statements regarding AI video creative features and overstating AI model improvements. Investors with losses are encouraged to secure counsel before upcoming deadlines.

Alphabet stock fell 3.8% on September 23, 2026, significantly underperforming the broader market's 0.76% decline. Despite strong earnings projections showing 2.09% EPS growth and 27.2% revenue growth for the upcoming quarter, the stock holds a Zacks Rank #3 (Hold) rating with a Forward P/E of 17.12, trading at a premium to its industry average of 16.02.

Novo Nordisk received positive regulatory recommendations in Europe for Frehemgo (hemophilia A treatment) and Sogroya (growth hormone therapy for multiple indications), potentially diversifying revenue beyond its pressured GLP-1 portfolio. However, the company faces intensifying competition from Eli Lilly's blockbuster GLP-1 drugs and smaller biotechs, with Novo's stock underperforming the industry year-to-date.

Pomerantz LLP is investigating potential securities fraud claims against Corning Incorporated following the company's announcement of a $2 billion at-the-market equity offering with Goldman Sachs on September 11, 2026. The announcement triggered a significant stock price decline of $22.80 per share (13.7%) to $143.60 on September 14, 2026. Investors are being invited to join the class action investigation.

A securities class action lawsuit has been filed against The Simply Good Foods Company regarding materially false and misleading statements about the OWYN acquisition. The lawsuit alleges the company failed to disclose key managerial losses, product quality issues with the new pea protein supplier, ineffective promotional activities, and failure to achieve strategic integration goals. The lead plaintiff deadline is October 13, 2026.

Rosen Law Firm is reminding investors in GoDaddy Inc., Alibaba Group Holding Limited, and The Simply Good Foods Company of upcoming lead plaintiff deadlines in securities class action lawsuits. The GoDaddy case alleges the company made false statements about customer growth strategy and average order size, implementing promotions that contradicted public representations and led to decreased bookings growth.

Rosen Law Firm has filed class action lawsuits against AST SpaceMobile, Inc. and other companies on behalf of investors who suffered losses. The lawsuit alleges that AST SpaceMobile made false statements regarding its capital requirements, competitive position, and user adoption rates, leading to investor damages when the true details emerged.